Evidence map›Paper›PMID 37899701›Full record

ArticleJournal of cachexia, sarcopenia and muscle2023

Exogenous H

Shiwu Zhang, Mengyi Wang, Hongxia Li, Qianzhu Li, Ning Liu, Shiyun Dong, Yajun Zhao, Kemiao Pang, Jiayi Huang, Cheng Ren and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. HFrontiers in cell and developmental biology · 2026
    Review
  5. Article
  6. Review
  7. AAV9-mediated gene supplementation therapy prevents and rescues arrhythmogenic cardiomyopathy in Pnpla2-mutated mice.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  8. Article
  9. Review
  10. Protective Role of HDiabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Review
  11. Article
  12. Exogenous HJournal of cachexia, sarcopenia and muscle · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Shiwu ZhangDepartment of Pathophysiology, Harbin Medical University, Harbin, China.ORCID 0000-0003-3983-4654
Mengyi WangDepartment of Pathophysiology, Harbin Medical University, Harbin, China.
Hongxia LiDepartment of Pathophysiology, Harbin Medical University, Harbin, China.
Qianzhu LiDepartment of Pathophysiology, Harbin Medical University, Harbin, China.
Ning LiuDepartment of Pathophysiology, Harbin Medical University, Harbin, China.
Shiyun DongDepartment of Pathophysiology, Harbin Medical University, Harbin, China.
Yajun ZhaoDepartment of Pathophysiology, Harbin Medical University, Harbin, China.
Kemiao PangDepartment of Pathophysiology, Harbin Medical University, Harbin, China.
Jiayi HuangDepartment of Pathophysiology, Harbin Medical University, Harbin, China.
Cheng RenDepartment of Urologic Surgery, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Yan WangDepartment of Urologic Surgery, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Zhen TianDepartment of Pathophysiology, Harbin Medical University, Harbin, China.
Fanghao LuDepartment of Pathophysiology, Harbin Medical University, Harbin, China.
Weihua ZhangDepartment of Pathophysiology, Harbin Medical University, Harbin, China.
Harbin Medical University · CN

Funding

National Natural Science Foundation of China 81970317National Natural Science Foundation of China 81970411National Natural Science Foundation of China 82270359
6 · The paper itself

Abstract

backgroundDiabetic cardiomyopathy, a distinctive complication of diabetes mellitus, has been correlated with the presence of intracellular lipid deposits. However, the intricate molecular mechanisms governing the aberrant accumulation of lipid droplets within cardiomyocytes remain to be comprehensively elucidated.

methodsBoth obese diabetic (db/db) mice and HL-1 cells treated with 200 μmol/L palmitate and 200 μmol/L oleate were used to simulate type 2 diabetes conditions. Transmission electron microscopy is employed to assess the size and quantity of lipid droplets in the mouse hearts. Transcriptomics analysis was utilized to interrogate mRNA levels. Lipidomics and ubiquitinomics were employed to explore the lipid composition alterations and proteins participating in ubiquitin-mediated degradation in mice. Clinical data were collected from patients with diabetes-associated cardiomyopathy and healthy controls. Western blot analysis was conducted to assess the levels of proteins linked to lipid metabolism, and the biotin-switch assay was employed to quantify protein cysteine S-sulfhydration levels.

resultsThe administration of H

conclusionsExogenous H

Indexed as

Diabetes Mellitus, Type 2Diabetic CardiomyopathiesAnimalsCystathionine gamma-LyaseCysteineHumansLipidsMiceSterol Regulatory Element Binding Protein 1SulfidesTriglyceridesUbiquitinUbiquitin-Protein LigasesCystathionine gamma-LyaseCysteineLipidssodium bisulfideSREBF1 protein, humanSrebf1 protein, mouseSterol Regulatory Element Binding Protein 1SulfidesSYVN1 protein, humanSyvn1 protein, mouseTriglyceridesUbiquitinUbiquitin-Protein LigasesDiabetic cardiomyopathyHydrogen sulfideLipid dropletsSterol regulatory element binding protein 1Synoviolin

Identifiers

PMID37899701
PMCPMC10751422
OpenAlexW4388014158

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.